"Our physicians, nurse practitioners and staff are committed to providing the best in the modern science and art of neurology to all those who seek our services including our patients, their families, our students, colleagues and community organizations."

During the past decade, Guilford Neurologic Research, PA conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Guilford Neurologic Research, PA" are "Alzheimer Disease" (2 trials), "Brain Diseases" (1 trials), "Central Nervous System Diseases" (1 trials), "Cognitive Impairment" (1 trials) and "Dementia" (1 trials). Many other conditions were trialed in "Guilford Neurologic Research, PA" in a lesser frequency.

Most popular intervention types in "Guilford Neurologic Research, PA" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Donanemab" (1 trials), "No Intervention" (1 trials), "Placebo" (1 trials), "RPC-1063" (1 trials) and "donanemab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Guilford Neurologic Research, PA" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Guilford Neurologic Research, PA". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Guilford Neurologic Research, PA, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Guilford Neurologic Research, PA, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".